Evidence map›Paper›PMID 28634241›Full record

ArticlemBio2017

Psl Produced by Mucoid

Christopher J Jones, Daniel J Wozniak

Abstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. A broad-host-range inhalable phage cocktail for treatment of multidrug-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  5. Review
  6. Article
  7. Complementary killing activities ofAntimicrobial agents and chemotherapy · 2025
    Article
  8. Review
  9. Synthesis of the Pentasaccharide Unit of theMolecules (Basel, Switzerland) · 2025
    Article
  10. Diversification ofMicroorganisms · 2025
    Article
  11. Applying a polysaccharide lyase fromApplied and environmental microbiology · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Impact ofPathogens (Basel, Switzerland) · 2023
    Article
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christopher J JonesCenter for Microbial Interface Biology and Department of Microbial Infection and Immunity, Ohio State University, Columbus, Ohio, USA christopher.joseph.jones@gmail.com.
Daniel J WozniakCenter for Microbial Interface Biology and Department of Microbial Infection and Immunity, Ohio State University, Columbus, Ohio, USA.

Funding

MOLECULAR MECHANISMS OF LUNG INFLAMMATIONT32HL007946 · NHLBI · OHIO STATE UNIVERSITY · PI WEWERS, MARK DAMIAN · 2000 to 2017
$3.1M
Revisiting alginate paradigmsR01AI134895 · NIAID · OHIO STATE UNIVERSITY · PI WOZNIAK, DANIEL J · 2018 to 2022
$2.5M
Pseudomonas biofilms and immunityR01AI097511 · NIAID · OHIO STATE UNIVERSITY · PI WOZNIAK, DANIEL J · 2013 to 2017
$1.9M
NHLBI NIH HHS T32 HL007946NIAID NIH HHS R01 AI097511NIAID NIH HHS R01 AI134895
6 · The paper itself

Abstract

Despite years of research and clinical advances, chronic pulmonary infections with mucoid

Indexed as

Immune EvasionAnimalsBacterial AdhesionBiofilmsCell LineComplement System ProteinsDisease Models, AnimalEpithelial CellsHumansMiceMicrobial ViabilityOpsonin ProteinsPolysaccharides, BacterialProtein BindingPseudomonas aeruginosaPseudomonas InfectionsComplement System ProteinsOpsonin ProteinsPolysaccharides, Bacterialbiofilmscystic fibrosisexopolysaccharideimmune evasionlung infectionPseudomonas aeruginosa

Identifiers

PMID28634241
PMCPMC5478896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.